Top

Molecular and Cellular Pediatrics

Published in:

Open Access 01-12-2014 | Mini review

Fanconi anemia: young patients at high risk for squamous cell carcinoma

Authors: Eunike Velleuer, Ralf Dietrich

Published in: Molecular and Cellular Pediatrics | Issue 1/2014

Abstract

Background

Fanconi anemia is one of the best studied inherited cancer-prone diseases. Greatly improved protocols for hematopoietic stem cell transplantation increasingly save the lives of these young patients. However, in both transplanted and not transplanted patients, the emergence of aggressive squamous cell carcinoma represents a major medical challenge.

Conclusions

This mini review summarizes current knowledge about the pathogenesis of squamous cell carcinoma (SCC) in the special context of Fanconi anemia.

Available only for authorised users

Alter BP, Joenje H, Oostra AB, Pals G: Fanconi anemia: adult head and neck cancer and hematopoietic mosaicism. Arch Otolaryngol Head Neck Surg 2005, 131(7):635–639. 10.1001/archotol.131.7.635CrossRef

Alter BP: Cancer in Fanconi anemia, 1927–2001. Cancer 2003, 97(2):425–440. 10.1002/cncr.11046CrossRef

Alter BP: Fanconi's anemia, transplantation, and cancer. Pediatr Transplant 2005, 9(Suppl 7):81–86. 10.1111/j.1399-3046.2005.00440.xCrossRef

Kutler DI, Auerbach AD, Satagopan J, Giampietro PF, Batish SD, Huvos AG, Goberdhan A, Shah JP, Singh B: High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg 2003, 129(1):106–112. 10.1001/archotol.129.1.106CrossRef

Rosenberg PS, Socié G, Alter BP, Gluckman E: Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 2005, 105(1):67–73. 10.1182/blood-2004-04-1652CrossRef

Masserot C, Peffault de Latour R, Rocha V, Leblanc T, Rigolet A, Pascal F, Janin A, Soulier J, Gluckman E, Socié G: Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation. Cancer 2008, 113(12):3315–3322. 10.1002/cncr.23954CrossRef

Kalb R, Duerr M, Wagner M, Herterich S, Gross M, Digweed M, Joenje H, Hoehn H, Schindler D: Lack of sensitivity of primary Fanconi's anemia fibroblasts to UV and ionizing radiation. Radiat Res 2004, 161(3):318–325. 10.1667/RR3138CrossRef

Wong WM, Parvathaneni U, Jewell PD, Martins RG, Futran ND, Laramore GE, Liao JJ: Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature. Head Neck 2013, 35(10):E292-E298.

Joenje H, Arwert F, Eriksson AW, de Koning H, Oostra AB: Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature 1981, 290(5802):142–143. 10.1038/290142a0CrossRef

10.

Pagano G, Talamanca AA, Castello G, d'Ischia M, Pallardó FV, Petrović S, Porto B, Tiano L, Zatterale A: From clinical description, to in vitro and animal studies, and backward to patients: oxidative stress and mitochondrial dysfunction in Fanconi anemia. Free Radic Biol Med 2013, 58: 118–125. 10.1016/j.freeradbiomed.2013.01.015CrossRef

11.

Romick-Rosendale LE, Lui VW, Grandis JR, Wells SI: The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma. Mutat Res 2013, 743–744: 78–88. 10.1016/j.mrfmmm.2013.01.001CrossRef

12.

Ameziane N, Chen F, Leemans CR, Brakenhoff RH, Joenje H: No evidence for FANCF gene silencing in head-and-neck squamous cell carcinomas. Cell Oncol 2009, 31(1):53–56.

13.

Ghosh A, Maiti GP, Bandopadhyay MN, Chakraborty J, Biswas J, Roychoudhury S, Panda CK: Inactivation of 9q22.3 tumor suppressor genes predict outcome for patients with head and neck squamous cell carcinoma. Anticancer Res 2013, 33(3):1215–1220.

14.

Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D: Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996, 56(11):2488–2492.

15.

van Zeeburg HJ, Snijders PJ, Wu T, Gluckman E, Soulier J, Surralles J, Castella M, van der Wal JE, Wennerberg J, Califano J, Velleuer E, Dietrich R, Ebell W, Bloemena E, Joenje H, Leemans CR, Brakenhoff RH: Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 2008, 100(22):1649–1653. 10.1093/jnci/djn366CrossRef

16.

Radoi L, Paget-Bailly S, Cyr D, Papadopoulos A, Guida F, Schmaus A, Cénée S, Menvielle G, Carton M, Lapôtre-Ledoux B, Delafosse P, Stücker I, Luce D: Tobacco smoking, alcohol drinking and risk of oral cavity cancer by subsite: results of a French population-based case–control study, the ICARE study. Eur J Cancer Prev 2013, 22(3):268–276. 10.1097/CEJ.0b013e3283592cceCrossRef

17.

Kutler DI, Wreesmann VB, Goberdhan A, Ben-Porat L, Satagopan J, Ngai I, Huvos AG, Giampietro P, Levran O, Pujara K, Diotti R, Carlson D, Huryn LA, Auerbach AD, Singh B: Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 2003, 95(22):1718–1721. 10.1093/jnci/djg091CrossRef

18.

Alter BP, Giri N, Savage SA, Quint WG, de Koning MN, Schiffman M: Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: a search for human papillomavirus. Int J Cancer 2013, 133(6):1513–1515. 10.1002/ijc.28157CrossRef

19.

Langevin F, Crossan GP, Rosado IV, Arends MJ, Patel KJ: Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice. Nature 2011, 475(7354):53–58. 10.1038/nature10192CrossRef

20.

Hira A, Yabe H, Yoshida K, Okuno Y, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Nakamura J, Kojima S, Ogawa S, Matsuo K, Takata M, Yabe M: Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. Blood 2013, 122(18):3206–3209. 10.1182/blood-2013-06-507962CrossRef

21.

Marttila E, Uittamo J, Rusanen P, Lindqvist C, Salaspuro M, Rautemaa R: Acetaldehyde production and microbial colonization in oral squamous cell carcinoma and oral lichenoid disease. Oral Surg Oral Med Oral Pathol Oral Radiol 2013, 116(1):61–68. 10.1016/j.oooo.2013.02.009CrossRef

22.

Uittamo J, Nieminen MT, Kaihovaara P, Bowyer P, Salaspuro M, Rautemaa R: Xylitol inhibits carcinogenic acetaldehyde production by Candida species. Int J Cancer 2011, 129(8):2038–2041. 10.1002/ijc.25844CrossRef

Title: Fanconi anemia: young patients at high risk for squamous cell carcinoma
Authors: Eunike Velleuer
Ralf Dietrich
Publication date: 01-12-2014
Publisher: Springer Berlin Heidelberg
Published in: Molecular and Cellular Pediatrics / Issue 1/2014
Electronic ISSN: 2194-7791
DOI: https://doi.org/10.1186/s40348-014-0009-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Fanconi anemia: young patients at high risk for squamous cell carcinoma

Abstract

Background

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2014

Mechanisms of hypothermia-induced cell protection in the brain

Are microRNAs suitable biomarkers of immunity to tuberculosis?

Matrix metalloproteinases and epileptogenesis

Monogenic forms of childhood obesity due to mutations in the leptin gene

Cancer therapy: know your enemy?

Renal response to short- and long-term exercise in very-long-chain acyl-CoA dehydrogenase-deficient (VLCAD−/−) mice